Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (209) Precision Medicine (188) Precision Medicine and Genetics (86) Genomics and Bioinformatics for Clinical Use (51) Cancer Epidemiology, Cancer Surveillance and Infodemiology (129) Clinical Cancer Research (134) Chemotherapy and Side Effects Management (123) RCTs - Pilots/Feasibility Studies (non-eHealth) (55) Innovations in Cancer Diagnostic and Decision Support (122) Nephrology/Renal Disorders (112)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/72597, first published .
Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled Trial

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled Trial

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled Trial

Authors of this article:

Yongle Zhan1 Author Orcid Image ;   Xiaohao Ruan2 Author Orcid Image ;   Yishuo Wu3 Author Orcid Image ;   Tsun Tsun Stacia Chun1 Author Orcid Image ;   Chi Yao1 Author Orcid Image ;   Ruofan Shi2 Author Orcid Image ;   Jiacheng Liu2 Author Orcid Image ;   Salida Ali1 Author Orcid Image ;   Ruochen Ma1 Author Orcid Image ;   Da Huang2 Author Orcid Image ;   Yi Gao2 Author Orcid Image ;   Ying Xu2 Author Orcid Image ;   Lu Chen2 Author Orcid Image ;   Qijun Du4 Author Orcid Image ;   Ada Tsui-Lin Ng5 Author Orcid Image ;   Cho Wing Bryan Li6 Author Orcid Image ;   Danfeng Xu2 Author Orcid Image ;   Rong Na1 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Goradia R, Goodstein T, Sundi D, Sood A, Dason S, Singer E. Using ctDNA to Inform Adjuvant Therapy for Urologic Malignancies. Cancers 2026;18(7):1121 View